{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T23:56:01Z","timestamp":1697327761205},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1097\/01.ju.0000165149.66186.23","type":"journal-article","created":{"date-parts":[[2005,7,4]],"date-time":"2005-07-04T09:32:58Z","timestamp":1120469578000},"page":"668-672","source":"Crossref","is-referenced-by-count":6,"title":["RESULTS OF COMPLIANCE WITH PROSTATE CANCER SCREENING GUIDELINES"],"prefix":"10.1097","volume":"174","author":[{"given":"ROBERT L.","family":"GRUBB","sequence":"first","affiliation":[{"name":"Division of Urology (RLG), Department of Psychiatry (KAR) and Department of Neurology (JVA), Washington University School of Medicine, St. Louis, Missouri, and the Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois (WJC, formerly from the Division of Urology, Washington University School of Medicine)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KIMBERLY A.","family":"ROEHL","sequence":"additional","affiliation":[{"name":"Division of Urology (RLG), Department of Psychiatry (KAR) and Department of Neurology (JVA), Washington University School of Medicine, St. Louis, Missouri, and the Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois (WJC, formerly from the Division of Urology, Washington University School of Medicine)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.O. ANN V.","family":"ANTENOR","sequence":"additional","affiliation":[{"name":"Division of Urology (RLG), Department of Psychiatry (KAR) and Department of Neurology (JVA), Washington University School of Medicine, St. Louis, Missouri, and the Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois (WJC, formerly from the Division of Urology, Washington University School of Medicine)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WILLIAM J.","family":"CATALONA","sequence":"additional","affiliation":[{"name":"Division of Urology (RLG), Department of Psychiatry (KAR) and Department of Neurology (JVA), Washington University School of Medicine, St. Louis, Missouri, and the Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois (WJC, formerly from the Division of Urology, Washington University School of Medicine)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1097\/01.ju.0000165149.66186.23_bib1","first-page":"267","article-title":"Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA)","volume":"14","year":"2000","journal-title":"Oncology"},{"key":"10.1097\/01.ju.0000165149.66186.23_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3322\/canjclin.54.1.41","article-title":"American Cancer Society guidelines for the early detection of cancer, 2004","volume":"54","author":"Smith","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"10.1097\/01.ju.0000165149.66186.23_bib3","unstructured":"National Comprehensive Cancer Network: Prostate Cancer. NCCN Clinical Practice Guidelines in Oncology\u2013version 1.2004. Available at http:\/\/www.nccn.org. Accessed January 31, 2005"},{"key":"10.1097\/01.ju.0000165149.66186.23_bib4","first-page":"480","article-title":"Screening for prostate cancer. American College of Physicians","volume":"126","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1097\/01.ju.0000165149.66186.23_bib5","series-title":"Screening for Prostate Cancer: Recommendations and Rationale","author":"U.S. Preventive Services Task Force","year":"2002"},{"key":"10.1097\/01.ju.0000165149.66186.23_bib6","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1852::AID-CNCR25>3.3.CO;2-H","article-title":"The early detection of prostate carcinoma with prostate specific antigen: the Washington University experience","volume":"80","author":"Smith","year":"1997","journal-title":"Cancer"},{"key":"10.1097\/01.ju.0000165149.66186.23_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-5347(17)38664-0","article-title":"Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate","volume":"142","author":"Hodge","year":"1989","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000165149.66186.23_bib8","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM199104253241702","article-title":"Measurement of prostate-specific antigen in serum as a screening test for prostate cancer","volume":"324","author":"Catalona","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1097\/01.ju.0000165149.66186.23_bib9","series-title":"Manual for Staging of Cancer","first-page":"181","author":"Beahrs","year":"1992"},{"key":"10.1097\/01.ju.0000165149.66186.23_bib10","first-page":"326","article-title":"Percentage carcinoma as a measure of prostatic tumor size in radical prostatectomy tissues","volume":"10","author":"Humphrey","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1097\/01.ju.0000165149.66186.23_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0022-5347(17)59889-4","article-title":"Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging","volume":"111","author":"Gleason","year":"1974","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000165149.66186.23_bib12","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1016\/S0022-5347(01)62200-6","article-title":"Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free\/total prostate specific antigen levels and needle biopsy findings","volume":"160","author":"Epstein","year":"1998","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000165149.66186.23_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF01300181","article-title":"Comparison of pathologic characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer","volume":"15","author":"Hoedemaeker","year":"1997","journal-title":"World J Urol"},{"key":"10.1097\/01.ju.0000165149.66186.23_bib14","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/S0022-5347(01)62204-3","article-title":"Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results","volume":"160","author":"Catalona","year":"1998","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000165149.66186.23_bib15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0022-5347(01)69079-7","article-title":"Cancer control with radical prostatectomy alone in 1,000 consecutive patients","volume":"167","author":"Hull","year":"2002","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000165149.66186.23_bib16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0090-4295(02)01875-7","article-title":"Prostate-specific antigen cutoff of 2.6 ng\/mL for prostate cancer screening is associated with favorable pathologic tumor features","volume":"60","author":"Krumholtz","year":"2002","journal-title":"Urology"},{"key":"10.1097\/01.ju.0000165149.66186.23_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa032975","article-title":"Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy","volume":"351","author":"D\u2019Amico","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1097\/01.ju.0000165149.66186.23_bib18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/jama.271.5.368","article-title":"Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer","volume":"271","author":"Epstein","year":"1994","journal-title":"JAMA"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534701683599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534701683599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1097\/01.ju.0000165149.66186.23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T06:49:37Z","timestamp":1651214977000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1097\/01.ju.0000165149.66186.23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["10.1097\/01.ju.0000165149.66186.23"],"URL":"https:\/\/doi.org\/10.1097\/01.ju.0000165149.66186.23","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}